Renerva Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $325K

  • Investors
  • 13

Renerva General Information

Description

Manufacturer of medical devices designed to improve healing following nerve injury. The company offers a nerve capping device, peripheral nerve matrix graft, sutureless neurorrhaphy device, implantable biomaterial matrix, nerve cap graft device, and tissue-based hydrogel, enabling medical professionals with tools to prevent neuroma formation and chronic pain.

Contact Information

Website
www.renerva.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2403 Sidney Street
  • Suite 280
  • Pittsburgh, PA 15203
  • United States
+1 (412)
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Corporate Office
  • 2403 Sidney Street
  • Suite 280
  • Pittsburgh, PA 15203
  • United States
+1 (412)

Renerva Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renerva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 30-Sep-2025 $325K Completed Clinical Trials - General
14. Later Stage VC 15-Aug-2024 Completed Clinical Trials - General
13. Grant 01-Jan-2023 Completed Clinical Trials - General
12. Grant 24-Feb-2022 Completed Clinical Trials - General
11. Early Stage VC 01-Jun-2021 Completed Clinical Trials - General
10. Accelerator/Incubator 09-Jan-2020 Completed Clinical Trials - General
9. Grant 01-Sep-2019 Completed Clinical Trials - General
8. Grant 01-Jul-2019 Completed Clinical Trials - General
7. Seed Round 30-Apr-2019 $960K $2.02M Completed Clinical Trials - General
6. Grant 14-Dec-2018 $2.44M $1.06M Completed Startup
To view Renerva’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Renerva Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of medical devices designed to improve healing following nerve injury. The company offers a nerve capping d
Therapeutic Devices
Pittsburgh, PA
10 As of 2026

Birkerod, Denmark
 

Shelton, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Renerva Competitors (4)

One of Renerva’s 4 competitors is Reapplix, a Venture Capital-Backed company based in Birkerod, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Reapplix Venture Capital-Backed Birkerod, Denmark
Spine Wave Venture Capital-Backed Shelton, CT
Söring Private Equity-Backed Quickborn, Germany
Arthrex Private Equity-Backed Naples, FL
To view Renerva’s complete competitors history, request access »

Renerva Patents

Renerva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024411137-A1 Nerve graft systems, devices, and methods Pending 27-Dec-2023
EP-4832923-A1 Nerve graft systems, devices, and methods Pending 27-Dec-2023
WO-2025144768-A1 Nerve graft systems, devices, and methods Inactive 27-Dec-2023
AU-2022425103-A1 Neurorrhaphy systems, devices, and methods Pending 31-Dec-2021
AU-2022425103-A2 Neurorrhaphy systems, devices, and methods Pending 31-Dec-2021 A61B17/1128
To view Renerva’s complete patent history, request access »

Renerva Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Renerva Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chemical Angel Network Angel Group Minority
Cowtown Angels Angel Group Minority
Keiretsu Forum Angel Group Minority
Rochester Angel Network Angel Group Minority
Center for Life Science Ventures Accelerator/Incubator Minority
You’re viewing 5 of 13 investors. Get the full list »

Renerva FAQs

  • When was Renerva founded?

    Renerva was founded in 2017.

  • Where is Renerva headquartered?

    Renerva is headquartered in Pittsburgh, PA.

  • What is the size of Renerva?

    Renerva has 10 total employees.

  • What industry is Renerva in?

    Renerva’s primary industry is Therapeutic Devices.

  • Is Renerva a private or public company?

    Renerva is a Private company.

  • What is Renerva’s current revenue?

    The current revenue for Renerva is .

  • How much funding has Renerva raised over time?

    Renerva has raised $2.98M.

  • Who are Renerva’s investors?

    Chemical Angel Network, Cowtown Angels, Keiretsu Forum, Rochester Angel Network, and Center for Life Science Ventures are 5 of 13 investors who have invested in Renerva.

  • Who are Renerva’s competitors?

    Reapplix, Spine Wave, Söring, and Arthrex are competitors of Renerva.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process